The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsiamet Res Regulatory News (ARS)

Share Price Information for Asiamet Res (ARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.50
Bid: 1.45
Ask: 1.55
Change: -0.025 (-1.64%)
Spread: 0.10 (6.897%)
Open: 1.55
High: 1.55
Low: 1.50
Prev. Close: 1.525
ARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2020 Annual Report & Financial Statements

24 May 2021 12:45

RNS Number : 6115Z
Asiamet Resources Limited
24 May 2021
 

24 May 2021

 

 

2020 Annual Report & Financial Statements

 

Asiamet Resources Limited ("Asiamet" or the "Company") is pleased to present its audited financial statements for the 12 months ended 31 December 2020 ("Financial Statements") as extracted from the Company's 2020 Annual Report which is now available on the Company website at www.asiametresources.com and will be provided to shareholders who have requested a printed or electronic copy.

The Financial Statements are set out below and should be read in conjunction with the 2020 Annual Report which contains the notes to the Financial Statements.

All dollars in the report are US$ unless otherwise stated.

2020 Financial and Operational Highlights Include:

· Relocation of Head Office and Corporate function from Melbourne to Jakarta.

· Capital placing raising gross proceeds of approximately $3.9 million completed in March 2020.

· Final approval of the Further Exploration Permit for the KSK CoW received from Badan Koordinasi Penanaman Modal ("BKPM"), the investment co-ordinating body in Indonesia.

· The Company signed a conditional binding Share and Purchase Agreement ("SPA") with PT Wasesa Indo Nusa ("PT WIN") in December 2020. This was subsequently terminated in January 2021 when PT WIN did not fulfil its obligations under the binding SPA.

· Continuation of value enhancement activities for the BKM Project. Metallurgical test work completed during the year and in early 2021 confirmed the opportunity to revise the ore processing method which has the potential to increase life-of-mine copper recoveries by 40% on a relative basis.

Key Subsequent Events Include:

· Capital placing raising gross proceeds of approximately $14 million completed in February 2020.

· Appointment of Eva Armila Djauhari as a Non-executive Director.

 

ON BEHALF OF THE BOARD OF DIRECTORS

Antony (Tony) Manini, Executive Chairman

For further information, please contact:-Ends-

Tony ManiniExecutive Chairman, Asiamet Resources LimitedEmail: tony.manini@asiametresources.com

 

FlowComms Limited - Investor Relations

Sasha Sethi

Telephone: +44 (0) 7891 677 441

Email: Sasha@flowcomms.com

Asiamet Resources Nominated AdviserRFC Ambrian Limited

Bhavesh Patel / Stephen Allen

Telephone: +44 (0)20 3440 6800

Email: Bhavesh.Patel@rfcambrian.com / Stephen.Allen@rfcambrian.com 

 

Optiva Securities LimitedChristian Dennis

Telephone: +44 20 3137 1903

Email: Christian.Dennis@optivasecurities.com

 

Follow us on twitter @AsiametTweets

 

FORWARD-LOOKING STATEMENT

This news release contains forward-looking statements that are based on the Company's current expectations and estimates. Forward-looking statements are frequently characterised by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "suggest", "indicate" and other similar words or statements that certain events or conditions "may" or "will" occur. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such factors include, among others: the actual results of current exploration activities; conclusions of economic evaluations; changes in project parameters as plans continue to be refined; possible variations in ore grade or recovery rates; accidents, labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing; and fluctuations in metal prices. There may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

 

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 ("MAR").

 

 

Consolidated Statement of Financial Position

As at 31 December 2020

 

2020

2019

 $'000

 $'000

Assets

Current assets

Cash

 1,179

 418

Receivables and other assets

 4

 50

 1,183

 468

Assets classified as held for sale

 125

 -

 1,308

 468

Non-current assets

Plant and equipment

 39

 197

Right-of-use assets

 3

 236

Receivables and other assets

 5

86

 47

 519

Total assets

 1,355

 987

Liabilities and Equity

Current liabilities

Trade and other payables

 391

 396

Provisions

 253

 89

Lease liabilities

 278

 78

 922

 563

Liabilities directly associated with the assets classified as held for sale

 753

 -

 1,675

 563

Non-current liabilities

Provisions

 81

 473

Lease liabilities

-

 237

81

 710

Total liabilities

 1,756

 1,273

Equity

Share capital

 14,752

 10,969

Equity reserves

 56,661

 56,435

Other comprehensive income

 83

 74

Accumulated deficit

 (68,644)

 (64,511)

Other reserves

 (3,246)

 (3,246)

Parent entity interest

 (394)

 (279)

Non-controlling interest

 (7)

 (7)

 (401)

 (286)

Total liabilities and equity

 1,355

 987

 

 

 

Consolidated Statement of Comprehensive Loss

For the year ended 31 December 2020

2020

2019

 $'000

 $'000

Continuing Operations

Expenses

Exploration and evaluation

 (190)

 (640)

Employee benefits

 (960)

 (890)

Consultants

 (453)

 (359)

Legal and Company Secretarial

 (24)

 (17)

Accounting and audit

 (30)

 (83)

General and administrative

 (268)

 (383)

Depreciation

 (55)

 (110)

Share-based compensation

 (175)

 (298)

 (2,155)

 (2,780)

Other items

Foreign exchange gain

 354

 98

Interest income

 1

 2

Finance costs

 (27)

 (25)

Impairment expense

 (305)

 (46)

Other income

 71

 2

 94

 31

Net loss before tax from continuing operations

 (2,061)

 (2,749)

Income tax expense

 -

 -

Net loss for the year from continuing operations

 (2,061)

 (2,749)

Discontinued operations

Loss after tax for the year from discontinued operations

 (2,072)

 (4,434)

Net loss for the year

 (4,133)

 (7,183)

Item that may not be reclassified subsequently

to profit or loss:

Actuarial gain on employee service entitlements

 9

 64

Total comprehensive loss for the year

 (4,124)

 (7,119)

Net loss attributable to:

Equity holders of the parent

 (4,040)

 (6,995)

Non-controlling interests

 (93)

 (188)

Total comprehensive loss attributable to:

Equity holders of the parent

 (4,031)

 (6,931)

Non-controlling interests

 (93)

 (188)

Basic and diluted loss per common share

 (0.00)

 (0.01)

Weighted average number of shares outstanding (thousands)

 1,414,666

 1,044,185

Consolidated Statement of Cash Flows

For the year ended 31 December 2020

 

2020

2019

 $'000

 $'000

Operating activities

Loss before tax from continuing operations

(2,061)

(2,749)

Loss before tax from discontinued operations

(2,072)

(4,434)

Loss before tax

(4,133)

(7,183)

Adjustments for:

Share-based compensation

175

298

Depreciation

81

133

Settlement of consulting fees via issue of ARS shares

-

200

Net foreign exchange gain

(18)

(32)

Impairment expenses

335

724

Finance costs

27

26

Movements in provisions

271

198

Changes in working capital:

Receivables and other assets

34

27

Value Added Tax ("VAT")

-

(154)

Trade and other payables

258

(515)

(2,970)

(6,278)

Interest payments

(27)

(26)

Refund of security deposit

15

10

Net cash flows used in operating activities

(2,982)

(6,294)

Investing activity

Purchases of property, plant and equipment

(4)

(38)

Net cash flows used in investing activities

(4)

(38)

Financing activities

Payment of principal portion of lease liabilities

(80)

(48)

Proceeds from related party loans

380

-

Repayment of related party loans

(257)

-

Proceeds from warrants and options exercises

-

237

Proceeds from equity raising

3,775

4,133

Equity raising costs

(64)

(251)

Net cash flows from financing activities

3,754

4,071

Increase/(decrease) in cash

768

(2,261)

Cash at beginning of the year

418

2,679

Cash at end of the year

1,186

418

 

 

 

Consolidated Statement of Changes in Equity

For the year ended 31 December 2020

 

Total equity

Other

attributable

Non-

 Share

Equity

comprehensive

Accumulated

Other

to the

controlling

capital

reserves

income

deficit

reserves

parent

interests

Total

 $'000

$'000

$'000

$'000

$'000

$'000

$'000

$'000

Balance at 1 January 2019

 9,983

 52,804

 10

 (57,328)

 (3,246)

 2,223

 (7)

 2,216

Loss for the year

 -

 -

 -

 (6,995)

 -

 (6,995)

 (188)

 (7,183)

Other comprehensive income

 -

 -

 64

 -

 -

 64

 -

 64

Total comprehensive income

 -

 -

 64

 (6,995)

 -

 (6,931)

 (188)

 (7,119)

Transactions with owners in their capacity

as owners

Equity raising

 873

 3,260

 -

 -

 -

 4,133

 -

 4,133

Warrant exercises

 19

 122

 -

 -

 -

 141

 -

 141

Option exercises

 26

 70

 -

 -

 -

 96

 -

 96

Equity raising costs

 -

 (251)

 -

 -

 -

 (251)

 -

 (251)

Shares issued to consultant

 45

 155

 -

 -

 -

 200

 -

 200

Reclassify shares issued to directors

 23

 (23)

 -

 -

 -

 -

 -

 -

Share-based compensation

 -

 298

 -

 -

 -

 298

 -

 298

Contribution by parent in NCI

 -

 -

 -

 (188)

 -

 (188)

 188

 -

Balance at 31 December 2019

 10,969

 56,435

 74

 (64,511)

 (3,246)

 (279)

 (7)

 (286)

Consolidated Statement of Changes in Equity

For the year ended 31 December 2020

 

Total equity

Other

attributable

Non-

 Share

Equity

comprehensive

Accumulated

Other

to the

controlling

capital

reserves

income

deficit

reserves

parent

interests

Total

 $'000

$'000

$'000

$'000

$'000

$'000

$'000

$'000

Balance at 1 January 2020

 10,969

 56,435

 74

 (64,511)

 (3,246)

 (279)

 (7)

 (286)

Loss for the year

 -

 -

 -

 (4,040)

 -

 (4,040)

 (93)

 (4,133)

Other comprehensive income

 -

 -

 9

 -

 -

 9

 -

 9

Total comprehensive income

 -

 -

 9

 (4,040)

 -

 (4,031)

 (93)

 (4,124)

Transactions with owners in their capacity

as owners

Equity raising

 3,617

158

 -

 -

 -

 3,775

 -

 3,775

Related party loans converted to equity

117

6

-

-

-

123

-

123

Equity raising costs

 -

 (64)

 -

 -

 -

 (64)

 -

 (64)

Reclassify shares issued to directors

 49

 (49)

 -

 -

 -

 -

 -

 -

Share-based compensation

 -

 175

 -

 -

 -

 175

 -

 175

Contribution by parent in NCI

 -

 -

 -

 (93)

 -

 (93)

 93

 -

Balance at 31 December 2020

14,752

 56,661

 83

 (68,644)

 (3,246)

 (394)

 (7)

 (401)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR BBGDULXDDGBS
Date   Source Headline
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn
18th Jan 20212:01 pmRNSPrice Monitoring Extension
18th Jan 20211:00 pmRNSDeal Update – Sale Process
4th Jan 20219:00 amRNSImportant Environmental Approval Received for BKM
30th Dec 20204:30 pmRNSNotice of General Meeting
24th Dec 20208:30 amRNSSale and Purchase Agreement Executed
11th Dec 202011:00 amRNSCorporate Update – KSK Sale Process
16th Nov 202011:05 amRNSSecond Price Monitoring Extn
16th Nov 202011:00 amRNSPrice Monitoring Extension
13th Oct 202010:09 amRNSMedia and Presentation Links
8th Oct 20204:41 pmRNSSecond Price Monitoring Extn
8th Oct 20204:36 pmRNSPrice Monitoring Extension
8th Oct 20202:06 pmRNSSecond Price Monitoring Extn
8th Oct 20202:00 pmRNSPrice Monitoring Extension
8th Oct 202011:05 amRNSSecond Price Monitoring Extn
8th Oct 202011:00 amRNSPrice Monitoring Extension
8th Oct 20209:05 amRNSSecond Price Monitoring Extn
8th Oct 20209:00 amRNSPrice Monitoring Extension
8th Oct 20207:00 amRNSHeads of Agreement Signed for KSK
7th Sep 20209:35 amRNSAppointment of Crowe U.K. LLP as Auditor
28th Aug 20208:05 amRNSAppointment of Chief Financial Officer
20th Aug 20207:02 amRNS2020 Interim Financial Statements
13th Aug 202010:30 amRNSIssue of Director Performance Rights
7th Aug 202011:49 amRNSLink to Investor Call and Q&A
17th Jul 20201:32 pmRNSAsiamet Responds to Media Article
3rd Jul 202012:05 pmRNSAGM 2020 Q&A Session
30th Jun 20205:25 pmRNSResult of AGM
26th Jun 202010:50 amRNSCorporate Update
22nd Jun 20203:55 pmRNSAnnual General Meeting Update
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
28th May 20204:00 pmRNSNotice of Annual General Meeting
26th May 202011:05 amRNSSecond Price Monitoring Extn
26th May 202011:00 amRNSPrice Monitoring Extension
26th May 20208:45 amRNSCorporate Update
15th May 20209:05 amRNSSecond Price Monitoring Extn
15th May 20209:00 amRNSPrice Monitoring Extension
15th May 20207:00 amRNSAsiamet Receives Key Approval for BKM Project
5th May 20207:10 amRNS2019 Annual Report & Financial Statements
28th Apr 20209:01 amRNSKSK Receives Key Exploration Permit
7th Apr 20202:06 pmRNSSecond Price Monitoring Extn
7th Apr 20202:00 pmRNSPrice Monitoring Extension
27th Mar 20204:00 pmRNSCorrection of Admission Date
25th Mar 202010:22 amRNSStrategic Investment and Development Partner
25th Mar 20209:05 amRNSSecond Price Monitoring Extn
25th Mar 20209:00 amRNSPrice Monitoring Extension
13th Mar 20209:46 amRNSAsiamet Business Update
10th Mar 20202:05 pmRNSSecond Price Monitoring Extn
10th Mar 20202:00 pmRNSPrice Monitoring Extension
22nd Jan 20207:00 amRNSRelocates Head Office to Jakarta, Indonesia

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.